Douglas  Corley  to  Prevalence
                            
                            
                                This is a "connection" page, showing publications  Douglas  Corley  has written about  Prevalence.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.309
         
        
        
     
 
    
        
        - 
            Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
            
            
                Score: 0.083
            
         
        
        - 
            Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
            
            
                Score: 0.064
            
         
        
        - 
            Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Cancer Causes Control. 2020 Jan; 31(1):85-93.
            
            
                Score: 0.034
            
         
        
        - 
            Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting. . 2019 07 01; 81(3):284-291.
            
            
                Score: 0.033
            
         
        
        - 
            Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688.
            
            
                Score: 0.028
            
         
        
        - 
            Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Med. 2016 09; 5(9):2657-65.
            
            
                Score: 0.027
            
         
        
        - 
            Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8.
            
            
                Score: 0.022
            
         
        
        - 
            Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
            
            
                Score: 0.017